Previous researches showed that the incidence of TP53 mutations varied greatly in non-small cell lung cancer and was correlated with the pathological subtypes, reaching 81% in lung squamous cell carcinoma, 46% in lung adenocarcinoma [35], and 90% in small cell lung cancer [36]. This evidence concerns the gene TP53 and small cell lung carcinoma.